A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response

被引：0
作者：
Katrien De Wolf
Vibeke Kruse
Nora Sundahl
Mireille van Gele
Ines Chevolet
Reinhart Speeckaert
Lieve Brochez
Piet Ost
机构：
[1] University Hospital Ghent,Department of Radiation
[2] University Hospital Ghent,Oncology
[3] University Hospital Ghent,Department of Medical Oncology
来源：
Journal of Translational Medicine | / 15卷
关键词：
Cancer immunotherapy; Stereotactic body radiotherapy; Metastatic melanoma; Biomarkers; Immune monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 34 条
  • [11] Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
    Serrati, Simona
    Di Fonte, Roberta
    Porcelli, Letizia
    De Summa, Simona
    De Risi, Ivana
    Fucci, Livia
    Ruggieri, Eustachio
    Marvulli, Tommaso Maria
    Strippoli, Sabino
    Fasano, Rossella
    Rafaschieri, Tania
    Guida, Gabriella
    Guida, Michele
    Azzariti, Amalia
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [12] STEREOTACTIC BODY RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: INTERIM RESULTS OF A PROSPECTIVE PHASE II CLINICAL TRIAL
    King, Christopher R.
    Brooks, James D.
    Gill, Harcharan
    Pawlicki, Todd
    Cotrutz, Cristian
    Presti, Joseph C., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1043 - 1048
  • [13] Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-47 and anti-PD1 antibodies
    Frohne, Christopher C.
    Llano, Ernesto M.
    Perkovic, Ashley
    Cohen, Russell D.
    Luke, Jason J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [14] Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
    Simona Serratì
    Roberta Di Fonte
    Letizia Porcelli
    Simona De Summa
    Ivana De Risi
    Livia Fucci
    Eustachio Ruggieri
    Tommaso Maria Marvulli
    Sabino Strippoli
    Rossella Fasano
    Tania Rafaschieri
    Gabriella Guida
    Michele Guida
    Amalia Azzariti
    Journal of Experimental & Clinical Cancer Research, 42
  • [15] Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma
    Sundahl, Nora
    Vandekerkhove, Gillian
    Decaestecker, Karel
    Meireson, Annabel
    De Visschere, Pieter
    Fonteyne, Valerie
    Daan De Maeseneer
    Reynders, Dries
    Goetghebeur, Els
    Van Dorpe, Jo
    Verbeke, Sofie
    Annala, Matti
    Brochez, Lieve
    van der Eecken, Kim
    Wyatt, Alexander W.
    Rottey, Sylvie
    Ost, Piet
    EUROPEAN UROLOGY, 2019, 75 (05) : 707 - 711
  • [16] Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients
    Kasanen, Henna
    Hernberg, Micaela
    Makela, Siru
    Bruck, Oscar
    Juteau, Susanna
    Kohtamaki, Laura
    Ilander, Mette
    Mustjoki, Satu
    Kreutzman, Anna
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (05) : 717 - 730
  • [17] Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab
    Goutam, Siddhartha
    Stukalin, Igor
    Ewanchuk, Benjamin
    Sander, Michael
    Ding, Philip Q.
    Meyers, Daniel E.
    Heng, Daniel
    Cheung, Winson Y.
    Cheng, Tina
    CURRENT ONCOLOGY, 2022, 29 (10) : 7695 - 7704
  • [18] A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study
    Bestvina, Christine M.
    Pointer, Kelli B.
    Karrison, Theodore
    Al-Hallaq, Hania
    Hoffman, Philip C.
    Jelinek, Michael J.
    Juloori, Aditya
    Melotek, James M.
    Murgu, Septimiu
    Partouche, Julien
    Vokes, Everett E.
    Weichselbaum, Ralph R.
    Pitroda, Sean P.
    Patel, Jyoti D.
    Chmura, Steven J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (01) : 130 - 140
  • [19] Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients
    Henna Kasanen
    Micaela Hernberg
    Siru Mäkelä
    Oscar Brück
    Susanna Juteau
    Laura Kohtamäki
    Mette Ilander
    Satu Mustjoki
    Anna Kreutzman
    Cancer Immunology, Immunotherapy, 2020, 69 : 717 - 730
  • [20] Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
    Chen, Yi-Xing
    Yang, Ping
    Du, Shi-Suo
    Zhuang, Yuan
    Huang, Cheng
    Hu, Yong
    Zhu, Wen-Chao
    Yu, Yi-Yi
    Liu, Tian-Shu
    Zeng, Zhao-Chong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (24) : 3871 - 3882
1234